Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Hong Kong

About this trial

This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.

Eligibility criteria

Qualifiers

Aged 18 years or above;

Permanent residents of Dali City who have lived locally for at least six consecutive months;

Registered as rural residents;

No known history of diabetes;

Disqualifiers

Known history of T2DM or currently receiving glucose-lowering treatment;

HbA1c testing with a clear result within the past three months, or completion of standardised diabetes screening within the past six months;

Pregnant or breastfeeding at the time of recruitment;

Active thyroid disease or other active endocrine disorders at recruitment, such as Cushing's syndrome or acromegaly;

Trial design

Treatments tested in this trial

  • POC-cHbA1c
  • Fingerstick RBG

Treatment groups

720 Participants
are divided into 2 treatment groups

Sponsors and collaborators